https://www.zonebourse.com/cours/action/RADIOPHARM-THERANOSTICS-L-128455166/actualite/Radiopharm-Theranostics-recoit-la-designation-de-medicament-orphelin-de-la-FDA-pour-la-Trivehexin-43799606/?utm_source=telegram&utm_medium=social&utm_campaign=share